通过对结直肠腺癌和结直肠腺癌进行比较分析,揭示了结直肠腺癌的免疫组织化学和分子进化特征
Rei Ishikawa1, Hidetaka Yamada1, Hirotomo Saitsu2
1Department of Tumor Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, Shizuoka 431-3192, Japan.
Neoplasia (New York, N.Y.)
|May 22, 2025
概括
与结直肠腺癌 (CRAC) 相比,杰内叶腺癌 (JIAC) 呈现出明显的分子和进化特征. 这项研究确定了一种新的亚型,并揭示了JIAC.
科学领域:
- 在瘤学瘤学.
- 胃肠道癌症研究研究
- 分子病理学分子病理学
背景情况:
- 结核腺癌 (JIAC) 是一种罕见的疾病,对其临床病理学,遗传学和进化方面的数据有限.
- 了解JIAC的独特特征对于将其与更常见的结直肠腺癌 (CRAC) 区分开来至关重要.
研究的目的:
- 阐明JIAC和CRAC之间的临床病理学,遗传学和分子进化差异.
- 确定JIAC的新型亚型和预后标志物.
- 为了研究JIAC瘤发生的进化动态.
主要方法:
- 对52个JIAC和182个CRAC患者队列的比较分析.
- 使用34种主要抗体进行免疫组织化学染色.
- 多区域整体外体序列测序用于选定JIAC样本的遗传学和进化分析.
- 驱动基因突变和内异质性 (ITH) 的分析.
主要成果:
- 确定了一种新型亚型,即具有肠芽细胞分化 (JIAED) 的JIAC.
- 高MUC1表达和低Cyclin D1表达是JIAC的不良预后标志物.
- 在不匹配修复缺陷 (dMMR) -JIAC中,MSH2/MSH6损失比dMMR-CRAC更频繁.
- JIAC表现出一个"长干短分支"的基因结构,具有更高的变异性等位基因频率峰值.
- TP53和ARID2是熟练不匹配修复 (pMMR) - JIAC.的早期驱动突变.
- JIAC,pMMR和dMMR都主要遵循达尔文进化论,导致ITH比CRAC低.
结论:
- 与CRAC相比,JIAC具有不同的病理学和分子进化特征.
- 已识别的亚型和预后标记可能有助于JIAC管理.
- 了解JIAC独特的进化轨迹为改善治疗策略提供了潜力.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...